0.4752
0.0062 (1.32%)
0.0062 (1.32%)
Upgrade to Real-Time
Premarket
Low
0.2645
High
1.57
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Advaxis Inc | ADXS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.0062 | 1.32% | 0.4752 | 08:07:27 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.469 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.473 | 0.475 | 0.002 | - | - |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 130 | 61,300 | 14,330,201 | 0.2645 - 1.57 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:07:27 | 92 | $ 0.4752 | USD |
Advaxis Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 52.19M | 109.82M | 109.76M | $ 20.88M | $ - | 0.02 | -1.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Advaxis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADXS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.65 | 0.6549 | 0.462 | 0.5372348 | 6,712,324 | -0.1748 | -26.89% |
| 1 Month | 0.8677 | 0.87 | 0.462 | 0.6540887 | 4,005,058 | -0.3925 | -45.23% |
| 3 Months | 0.7665 | 1.57 | 0.462 | 0.9319691 | 9,815,863 | -0.2913 | -38.0% |
| 6 Months | 0.4118 | 1.57 | 0.2645 | 0.6984057 | 9,749,854 | 0.0634 | 15.4% |
| 1 Year | 0.64 | 1.57 | 0.2645 | 0.6835389 | 5,391,824 | -0.1648 | -25.75% |
| 3 Years | 1.73 | 10.80 | 0.181 | 0.7374337 | 3,567,267 | -1.25 | -72.53% |
| 5 Years | 9.79 | 16.295 | 0.181 | 1.55 | 2,466,545 | -9.31 | -95.15% |
Advaxis Description
| Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer. |
